Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Pierfranco Conte

1-50 of 275 results

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

scientific article

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

scientific article published on 7 October 2016

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

scientific article published on 08 January 2014

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

scientific article published on 02 July 2007

Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer.

scientific article

Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy

scientific article published on 13 April 2010

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.

scientific article published in January 2006

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

scientific article published on September 1996

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

scientific article published on 01 June 1996

Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies

scientific article

Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation.

scientific article published on 11 May 2009

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group

scientific article

Safety of intravenous and oral bisphosphonates and compliance with dosing regimens

scientific article published in January 2004

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

scientific article published on 7 November 2016

Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

scientific article published on 2 April 2010

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

scientific article published on 20 May 2015

Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization

scientific article published on 01 December 1995

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

scientific article published on 23 July 2008

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

scientific article

Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

scientific article published on 01 March 2002

The curability of breast cancer and the treatment of advanced disease.

scientific article published on 24 April 2004

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

article

Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs.

scientific article

Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy

scientific article published on 16 July 2009

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.

scientific article

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

scientific article published on 17 December 2015

Significance of lymph node sampling in epithelial carcinoma of the ovary.

scientific article published on June 1997

Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

scientific article published on 18 April 2007

Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma

scientific article published on 27 December 2011

Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.

scientific article published on 24 August 2009

Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest

scientific article published on 01 February 2000

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study

scientific article published on 20 June 2016

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients.

scientific article

Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer

scientific article published on 01 July 1997

Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial

scientific article published on 01 January 1998

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

scientific article published on January 2011

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer

scientific article

Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study

scientific article published on 01 February 2000

Rare breast cancer subtypes: histological, molecular, and clinical peculiarities

scientific article

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.

scientific article published on 27 November 2007

Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years.

scientific article published in November 2005

Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.

scientific article

A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer

scientific article published on 01 June 1986

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer

scientific article published on January 21, 2012

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.

scientific article published on July 2005

Gene expression profiling in breast cancer: a clinical perspective.

scientific article published on 23 February 2013

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer.

scientific article published on 8 October 2009

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial

scientific article published on 29 September 2019

Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.

scientific article

Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates.

scientific article